• Home
  • About
    • Corporate
    • Board
    • Management
  • R & D
    • Pipeline
    • Diabetes
    • Obesity
    • Gene Expression Signature Platform
  • Investors
    • Public Disclosure Policy
    • News & Articles
    • Notices and Reports
    • Scientific Publications & Presentations
    • Subscribe
  • Contact

Subscribe

Subscribe, Verva Pharmaceuticals - Biotech Australia

If you would like to be updated by email on Verva news and events, simply submit your email address in the form below.

      Investors

    • Public Disclosure Policy
    • News & Articles
    • Notices and Reports
    • Scientific Publications & Presentations
    • Subscribe
  • Recent News

    • Isis Initiates Phase 1 Clinical Trial of ISIS-FGFR4Rx a Peripherally Acting Drug to Treat Obesity
    • Investment in Verva by the Medical Research Commercialisation Fund (MRCF)
  • Subscribe
  • Contact